| Megan Gayer, | |
|
4400 W 69th St Ste 100, Sioux Falls, SD 57108-8172 | |
| (605) 322-4056 | |
| (605) 504-3548 |
| Full Name | Megan Gayer |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4400 W 69th St Ste 100, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164141172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6053 (South Dakota) | Primary |
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
The U.S. Food and Drug Administration today issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils (tonsillectomy) and/or adenoids (adenoidectomy).
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.
Profil Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just weeks after the Food and Drug Administration (FDA) approved Cook Medical's Zilver PTX Drug-Eluting Peripheral Stent, Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook's U.S. commercial launch.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Gayer, 1908 S Lincoln Ave, Sioux Falls, SD 57105-2331 Ph: (605) 496-1521 | Megan Gayer, 4400 W 69th St Ste 100, Sioux Falls, SD 57108-8172 Ph: (605) 322-4056 |
News Archive
The U.S. Food and Drug Administration today issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils (tonsillectomy) and/or adenoids (adenoidectomy).
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.
Profil Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.
Angion Biomedica Corp., a biopharmaceutical company dedicated to the discovery and development of novel therapeutics that enhance quality of life, eradicate disease and save lives by modulating the body's protective, reparative and regenerative systems, announced today that its lead therapeutic BB3 was accepted into the Fast Track program of the U.S. Food and Drug Administration (FDA) and has also been designated an Orphan Drug product by FDA.
Just weeks after the Food and Drug Administration (FDA) approved Cook Medical's Zilver PTX Drug-Eluting Peripheral Stent, Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook's U.S. commercial launch.
› Verified 7 days ago
Malia Holbeck, CSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2412 S Cliff Ave, Ste 200, Sioux Falls, SD 57105 Phone: 605-322-4079 | |
Lacey Ballew, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1000 E 23rd St, Sioux Falls, SD 57105 Phone: 056-322-7549 | |
Jill Walerius, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4105 S Carnegie Pl Ste 103, Sioux Falls, SD 57106 Phone: 605-212-3638 | |
Mrs. Robyn Shores Foster, CSW PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2109 S Norton Ave, Sioux Falls, SD 57105 Phone: 605-334-2696 Fax: 605-339-9944 | |
Alicia Mefferd, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 705 E 41st St Ste 100, Sioux Falls, SD 57105 Phone: 605-444-7500 | |
Mrs. Amber J Corey, LCSW-PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 W 49th St Ste 103, Sioux Falls, SD 57105 Phone: 605-271-4813 Fax: 605-271-4815 | |
Alexzander John Capell, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 801 N Sycamore Ave, Sioux Falls, SD 57110 Phone: 605-965-3109 |